Epileptogenic effects of NMDAR antibodies in a passive transfer mouse model.
about
Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous systemProgress in autoimmune epileptic encephalitisNeuroinflammation: Ways in Which the Immune System Affects the BrainAntibody-Mediated Autoimmune Encephalopathies and ImmunotherapiesHello from the Other Side: How Autoantibodies Circumvent the Blood-Brain Barrier in Autoimmune Encephalitis.Advances in Autoimmune Epilepsy Associated with Antibodies, Their Potential Pathogenic Molecular Mechanisms, and Current Recommended ImmunotherapiesAnti-N-Methyl-D-aspartate Receptor Encephalitis: A Severe, Potentially Reversible Autoimmune Encephalitis.Dopamine-2 receptor extracellular N-terminus regulates receptor surface availability and is the target of human pathogenic antibodies from children with movement and psychiatric disorders.Synaptic and Neuronal Autoantibody-Associated Psychiatric Syndromes: Controversies and HypothesesPediatric Autoimmune Epileptic Encephalopathies.Seizures and risk of epilepsy in autoimmune and other inflammatory encephalitis.Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System.Psychosis: an autoimmune disease?Ephrin-B2 prevents N-methyl-D-aspartate receptor antibody effects on memory and neuroplasticity.Epileptic syndrome in systemic lupus erythematosus and neuronal autoantibody associations.Treatment strategies for autoimmune encephalitis.Postherpes simplex encephalitis: a case series of viral-triggered autoimmunity, synaptic autoantibodies and response to therapy.
P2860
Q28075974-9691D29A-485D-4F72-BA33-8E3D253E0B21Q28077159-0D9A0830-E1B8-436D-9474-38AACD5D673BQ28080620-46947EC9-E104-4906-A177-C47F18C7F605Q28084055-307B0E8C-7230-415E-95D1-233ECE27ADA5Q33586199-DCB3E57E-6E98-4C1B-8DEC-326D9D8572B5Q33600142-21639828-30D9-4912-9070-3B7F7C7B31F7Q33862239-BEBE5FA6-37CA-46A9-B502-6762853200D5Q37466551-DC26DF4D-33DA-41BD-8DA1-351A362C558DQ37625400-39CE6E23-BEBC-41ED-B620-67DD7C470B13Q39068563-C359332A-B155-4B97-A671-B118295A7EFEQ39149611-272A247E-FAF4-4465-8B3D-9180C86CAD7FQ39180685-AC9557F0-5E54-4929-94A5-F3BA6AB29885Q39432877-6F7929AC-9011-4B6C-B3CB-E96BEF772DB6Q48049299-BE396CD6-CBB0-4F23-B9D8-23DCD8993B53Q48873692-213C3EDA-A4CE-428F-9376-EB7D981A0E6BQ49213573-9E39BCE6-C12C-4A6A-AF19-C9CE1DE195C5Q54207301-15730FD1-D72E-4451-907F-EC79E6054B64
P2860
Epileptogenic effects of NMDAR antibodies in a passive transfer mouse model.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Epileptogenic effects of NMDAR antibodies in a passive transfer mouse model.
@en
Epileptogenic effects of NMDAR antibodies in a passive transfer mouse model.
@nl
type
label
Epileptogenic effects of NMDAR antibodies in a passive transfer mouse model.
@en
Epileptogenic effects of NMDAR antibodies in a passive transfer mouse model.
@nl
prefLabel
Epileptogenic effects of NMDAR antibodies in a passive transfer mouse model.
@en
Epileptogenic effects of NMDAR antibodies in a passive transfer mouse model.
@nl
P2093
P2860
P356
P1433
P1476
Epileptogenic effects of NMDAR antibodies in a passive transfer mouse model.
@en
P2093
A Louise Upton
Bethan Lang
Julian Bartram
Kevan Hashemi
Lukasz Stasiak
Sukhvir Wright
P2860
P304
P356
10.1093/BRAIN/AWV257
P407
P577
2015-09-15T00:00:00Z